Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Collaboration Agreement with Abbott for Phase 3 TECH-LVAD Trial On March 4, 2025, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced a ...

Medical Implants Market Size and Growth medical implants market was valued at US$ 102.52 Bn in 2022 and is forecast to reach a value of US$ ...

Cadrenal Therapeutics has partnered with Abbott for the TECH-LVAD trial to assess the safety and efficacy of tecarfarin in ...

Cadrenal Therapeutics, Inc. , a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapeutics, with the late-stage asset tecarfarin, a new oral Vitamin K ...

Cadrenal Therapeutics (CVKD) announced the signing of a Collaboration Agreement with Abbott (ABT) ( ABT) to support Cadrenal’s pivotal ...

One person dies every 33 seconds from heart disease, making it the leading cause of death in the United States. But for one man who had the odds stacked against ...

More than 20 years after his military service, Army veteran Terrill Giere continues to embody the resilience of a soldier. His journey has been marked by serious health ...

A medical-surgical team at the Mohammed V Military Hospital in Rabat has successfully implanted the first long-term cardio-circulatory support in a 39-year-old patient suffering from end-stage chronic ...

Right now, there is only one heart pump on the market offered for short and long-term treatment of heart failure. A national ...